Close

Rating History for BioXcel Therapeutics (BTAI) by UBS

More Stocks Rated by UBS | Latest Ratings for BTAI
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
3/13/2024 Colin Bristow Maintain Neutral
(N/A)		 3.50
(4.00)		  
 		   Details